Foundation Fighting Blindness
Foundation Fighting Blindness
Foundation Fighting Blindness
Sumitomo Pharma Receives FDA Orphan Drug Designation for Retinitis Pigmentosa Treatment
2 minutes Posted Mar 24, 2026 at 6:39 pm.
0:00
2:12
Download MP3
Show notes
Potential cell therapy, DSP-3077, gains special regulatory status to support development for inherited retinal disease.